Covid-19 – Page 3 – Go Retire Psychiatrist

We Got Our Vaccinations

I saw the headlines about how some people are skipping the Covid-19 and flu shots this year. But we decided to get them anyway.

Sena got both but they were pretty close together and one bandaid covered them.

FDA Approves Updated Covid-19 Vaccines to Better Protect Against Currently Circulating Variants

On August 22, 2024, the FDA authorized new Covid-19 vaccines (2024-2025) “to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA COVID-19 vaccines manufactured by ModernaTX Inc. and Pfizer Inc.”

CDC Covid Information

Often, I see news agency headlines claiming to have insider information about what’s going on with the Centers for Disease Control (CDC), FDA, etc. I respect the opinions of others about government agencies. On the other hand, I like to get information straight from the horse’s mouth.

With that in mind, here’s what the CDC says is important to know about the Covid-19 situation.

CDC ACIP Recommendations for Covid 19 Vaccine for 2024

The CDC ACIP recommended implementation of the 2024 Covid-19 vaccine and the timeline is in the implementation slide set. CDC plans to use CDC Everything messages. Insurance plans, including Medicare, will cover the cost.

Reminder: CDC ACIP Meeting June 26-28 on Vaccines Including Covid-19 and RSV

Just a reminder about the upcoming CDC ACIP meeting on vaccines, including RSV and Covid-19.

June CDC ACIP Meeting on Covid and Other Vaccines

There’s an upcoming meeting of the CDC Advisory Committee on Immunization Practices (ACIP) June 26-28, 2024. They’ll discuss the new Covid-19 vaccine and several other vaccines including RSV.

FDA VRBPAC Meeting: Vaccine Targeting Lineage JN.1 for Fall 2024

I didn’t get a chance to watch the June 5th FDA advisory committee meeting on the new vaccine formulation for Covid-19 for this fall. There is a nice summary on the Minnesota CIDRAP (Center for Infectious Disease Research & Policy).

The committee unanimously upvoted the selection of the JN.1 lineage strain (which includes JN.1, KP.2 etc) for Covid vaccines this fall in the U.S.

As usual, Director Dr. Jerry Weir’s slides (summary slides 22-26) provide excellent background and clear discussion.

FDA VRBPAC Meeting on Covid Vaccine for Fall of 2024

The voting question for today’s FDA VRBPAC Meeting on the Covid Vaccine strain for this fall is:

“For the 2024-2025 Formula of COVID-19 vaccines in the U.S., does the
committee recommend a monovalent JN.1-lineage vaccine composition?
Please vote “Yes” or “No” or “Abstain.”

The FDA Selection of the 2024-2025 Formula for COVID-19 vaccines briefing document has a thorough review on the issue.